Nokia

HEALTH EDLP

13/05/22 -"15 days ago, we were intrigued by the extent of the collapse in the Health sector (ex Pharmas) even though we had been consistently pointing to the sector's ridiculously high multiples over the last ..."

PDF page sample
Pages
46
Language
English
Published on
13/05/22
Download
You may also be interested by these reports :
28/08/26
Telenor’s (Add ; Norway) share price halved in 2022, not only due to rising interest rates affecting the sector, but also due to investor concerns ...
13/08/26
Shelly published good profitability and cash flow figures for Q2 and reiterated its guidance. The group more than reassured again on margins and ...
05/08/26
We are adjusting our model following a quarter with a mixed picture. On the one hand, commercial performance was solid, with strong organic growth ...
30/07/26
Vusion’s H1 2026 revenue rose 29% to €839m in adjusted terms, within the €800-900m guided range, but the underlying mix confirms the group’s ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO